A. The maternal serum alpha-fetoprotein (MSAFP) test does not identify Rh incompatibility. Rh incompatibility is typically evaluated through blood typing and antibody screening, not through the MSAFP test. B. While the MSAFP test is related to fetal development, it does not assess various markers of fetal well-being. Instead, it measures the level of alpha-fetoprotein in the maternal blood, which is specifically associated with neural tube defects. C. The MSAFP test is primarily used as a screening tool for neural tube defects, such as spina bifida, in the fetus. Elevated levels of alpha-fetoprotein can indicate spinal defects or other fetal abnormalities. D. The MSAFP test does not assess fetal lung maturity. Fetal lung maturity is usually determined later in pregnancy through other tests, such as amniocentesis, which evaluates surfactant levels in the amniotic fluid.